Clinical Trials on Epilepsies, Partial
Total 4931 results
-
UCB PharmaCompleted
-
UCB PharmaCompletedPartial EpilepsiesUnited States, Poland, United Kingdom, Switzerland, Hungary, Germany, Sweden, Lithuania
-
UCB BIOSCIENCES, Inc.CompletedPartial Epilepsies | Partial Onset SeizuresUnited States
-
UCB BIOSCIENCES, Inc.CompletedPartial EpilepsiesUnited States
-
UCB PharmaCompletedPartial EpilepsiesUnited States, Austria, Bulgaria, Czechia, Denmark, Finland, France, Greece, Italy, Mexico, Romania, Russian Federation, Spain, Switzerland, Turkey
-
Institut National de la Santé Et de la Recherche...Unknown
-
UCB BIOSCIENCES, Inc.CompletedPartial Epilepsies | Partial Onset SeizuresUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedEpilepsyUnited States, Germany
-
Bial - Portela C S.A.Completed
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
BiocodexRecruitingPharmacoresistant Focal EpilepsiesFrance
-
Rennes University HospitalCompleted
-
GlaxoSmithKlineWithdrawn
-
Supernus Pharmaceuticals, Inc.CompletedSafety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial EpilepsyPartial EpilepsyUnited States, Poland, Bulgaria, Romania, Canada, Russian Federation, Mexico, Croatia
-
Central Hospital, Nancy, FranceInstitut National de la Santé Et de la Recherche Médicale, France; CHU de Reims and other collaboratorsCompletedPartial EpilepsyFrance
-
Eisai Inc.CompletedEpilepsyAustralia, France, Poland, Germany, Spain, India, Serbia, Greece, Korea, Republic of, Russian Federation, Taiwan, Hungary, Italy, Sweden, Denmark, Slovakia, United Kingdom, South Africa
-
Mayo ClinicCompleted
-
Cyberonics, Inc.TerminatedEpilepsy | Partial EpilepsyCanada, Spain, Belgium, France, Germany, Italy, Netherlands, Norway, Sweden, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedPartial EpilepsyUnited States
-
University of MinnesotaCompleted
-
Supernus Pharmaceuticals, Inc.Melbourne HealthCompleted
-
University Hospital, ToulouseRecruiting
-
UCB PharmaCompleted
-
University Hospital, ToulouseCerCo, CNRS Cerco UMR5549 CHU Purpan Toulouse France; DIXI Medical, Besançon...Completed
-
Eisai Korea Inc.Completed
-
Korea UCB Co., Ltd.Completed
-
Bial - Portela C S.A.Completed
-
UCB PharmaCompleted
-
UCB PharmaCompleted
-
UCB PharmaCompleted
-
Hospices Civils de LyonUnknown
-
Desitin Arzneimittel GmbHFGK Clinical Research GmbHTerminated
-
PfizerCompletedEpilepsy, PartialUnited States, Germany
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingDrug Resistant Epilepsy | Pediatrics | Epilepsies, FocalFrance
-
University Hospital, GrenobleCompletedSurgery | Partial EpilepsyFrance
-
Emory UniversityPatient-Centered Outcomes Research InstituteTerminatedEpilepsy, Partial | Epilepsy, Localization RelatedUnited States
-
The Hospital for Sick ChildrenCompletedPartial Epilepsy | Localization-related EpilepsyCanada
-
Atlantic UniversityA.T. Still University of Health SciencesCompletedPartial Epilepsy | Focal Onset EpilepsyUnited States
-
SK Life Science, Inc.Approved for marketingPartial Epilepsy
-
UCB PharmaCompletedEpilepsy, PartialHong Kong, Malaysia, Philippines, Singapore, Taiwan, Thailand
-
Bial - Portela C S.A.Completed
-
GlaxoSmithKlineCompleted
-
Bial - Portela C S.A.SunovionCompletedPartial EpilepsyUnited States, Argentina, Germany, France, Belgium, Canada, Italy, Poland, Greece, Brazil, Cyprus
-
Bial - Portela C S.A.CompletedEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial SeizuresRefractory Partial EpilepsyPortugal
-
GlaxoSmithKlineCompletedEpilepsy, PartialUnited States, Korea, Republic of, Ukraine, Chile, Costa Rica, Russian Federation, Puerto Rico, Argentina
-
The Cleveland ClinicUCB PharmaCompletedPartial EpilepsyUnited States
-
UCB PharmaCompleted
-
UCB PharmaCompleted
-
Northeast Regional Epilepsy GroupPfizerTerminatedEpilepsy, Complex PartialUnited States